Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Growth Metrics
Income Statement
Others
Ratios

Indivior Pharmaceuticals (INDV) Exchange Rate Effect (2024 - 2025)

Indivior Pharmaceuticals has reported Exchange Rate Effect over the past 2 years, most recently at -$2.0 million for Q3 2025.

  • Quarterly results put Exchange Rate Effect at -$2.0 million for Q3 2025, down 100.0% from a year ago — trailing twelve months through Dec 2025 was -$2.0 million (changed N/A YoY), and the annual figure for FY2025 was -$1.0 million, changed.
  • Exchange Rate Effect for Q3 2025 was -$2.0 million at Indivior Pharmaceuticals, down from $1.0 million in the prior quarter.
  • Over the last five years, Exchange Rate Effect for INDV hit a ceiling of $1.0 million in Q4 2024 and a floor of -$2.0 million in Q3 2025.